Home LiteratureArticle Details
PMID: 3591312 Published · ppublish English Journal Article

In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.

Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology ·Vol. 95 ·No. 2 ·1987-04-00 ·Pages 147-9

Andreasen JJ, Andersen LP

Abstract

The in vitro susceptibility of recent Danish human clinical isolates of Campylobacter pyloridis to cimetidine, sucralfate, bismuth subsalicylate and sixteen antimicrobial agents was determined by an agar-dilution technique. Benzylpenicillin was the most active drug (MIC90 = 0.1 microgram/ml); ampicillin, erythromycin, gentamicin and ciprofloxacin were slightly less active. All strains were resistant to 100 micrograms sulfamethizole, and nalidixic acid also had little activity on weight basis. Of the three anti-peptic ulcer drugs, bismuth subsalicylate was most active (MIC90 25 micrograms/ml), but sucralfate and cimetidine also had antibacterial activity, although only little (MIC90 3200 micrograms/ml).

MeSH Terms
Anti-Bacterial Agents/pharmacology Bismuth Campylobacter/drug effects Cimetidine/pharmacology Humans Microbial Sensitivity Tests Organometallic Compounds/pharmacology Salicylates/pharmacology Sucralfate/pharmacology
Chemicals
Anti-Bacterial Agents Organometallic Compounds Salicylates Sucralfate bismuth subsalicylate Cimetidine Bismuth
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Andreasen J J
Andersen L P
Article Info
Journal
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology
Abbr.
Acta Pathol Microbiol Immunol Scand B
ISSN
0108-0180
Published
1987-04-00
Pages
147-9
Language
English
Region
Denmark
NLM ID
8206623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com